|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
10
|
|
pubmed:dateCreated |
2002-1-3
|
|
pubmed:abstractText |
The purpose of this study was to determine the feasibility of both lymphatic mapping and probe-guided primary tumor excision by use of intralesional tracer administration in clinically occult breast cancer.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
1068-9265
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
8
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
850-5
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:11776502-Adenocarcinoma,
pubmed-meshheading:11776502-Adult,
pubmed-meshheading:11776502-Aged,
pubmed-meshheading:11776502-Aged, 80 and over,
pubmed-meshheading:11776502-Breast Neoplasms,
pubmed-meshheading:11776502-Coloring Agents,
pubmed-meshheading:11776502-Feasibility Studies,
pubmed-meshheading:11776502-Female,
pubmed-meshheading:11776502-Humans,
pubmed-meshheading:11776502-Injections, Intralesional,
pubmed-meshheading:11776502-Lymph Nodes,
pubmed-meshheading:11776502-Lymphoscintigraphy,
pubmed-meshheading:11776502-Middle Aged,
pubmed-meshheading:11776502-Neoplasm Staging,
pubmed-meshheading:11776502-Radiopharmaceuticals,
pubmed-meshheading:11776502-Sentinel Lymph Node Biopsy,
pubmed-meshheading:11776502-Technetium Tc 99m Aggregated Albumin
|
|
pubmed:year |
2001
|
|
pubmed:articleTitle |
Single intralesional tracer dose for radio-guided excision of clinically occult breast cancer and sentinel node.
|
|
pubmed:affiliation |
Department of Surgery, The Netherlands Cancer Institute, Amsterdam. ptanis@nki.nl
|
|
pubmed:publicationType |
Journal Article
|
